Multiplex biomarker approach to cardiovascular diseases

• 来源期刊: 中国药理学报（英文版）
• 关键词: cardiac biomarkers multimarker approach Luminex planar array assays microbead assays cardiac troponins personalized medicine
• 年，卷（期）: 2018,（7）
• 页码范围: 1068-1072
• 页数: 5页
• 语种: 英文
• DOI: 10.1038/aps.2018.29

摘要

Personalized medicine is partly based on biomarker-guided diagnostics,therapy and prognosis,which is becoming an unavoidable concept in modern cardiology.However,the clinical significance of single biomarker studies is rather limited.A promising novel approach involves combining multiple markers into a multiplex panel,which could refine the management of a particular patient with cardiovascular pathology.Two principally different assay formats have been developed to facilitate simultaneous quantification of multiple antigens:planar array assays and microbead assays.These approaches may help to better evaluate the complexity and dynamic nature of pathologic processes and offer substantial cost and sample savings compared with traditional enzyme-linked immunosorbent assay (ELISA) measurements.However,a multiplex multimarker approach cannot become a generally disseminated method until analytical problems are solved and further studies confirming improved clinical outcomes are accomplished.These drawbacks underlie the fact that a limited number of systematic studies are available regarding the use of a multiplex biomarker approach in cardiovascular medicine to date.Our perspective underscores the significant potential of the use of the multiplex approach in a wider conceptual framework under the close cooperation of clinical and experimental cardiologists,pathophysiologists and biochemists so that the personalized approach based on standardized multimarker testing may improve the management of various cardiovascular pathologies and become a ubiquitous partner of population-derived evidence-based medicine.